BCEIE › News › SUDARSHAN

Fund raising

Sudarshan Pharma Industries allots ₹72 crore warrants

Sudarshan Pharma Industries (SUDARSHAN) said it has allotted warrants of ₹72 crore.

BCEIE News Desk · Published 30 Oct 2026, 08:49 pm IST · Filing received 30 Oct 2026, 08:33 pm IST

What happened

Sudarshan Pharma Industries (SUDARSHAN) told the exchanges on 30 October 2026 at 08:33 PM that it has allotted warrants of ₹72 crore.

From the filing: "Sudarshan Pharma Industries Limited has informed the Exchange about issue of Securities - In continuation of the Company's letter dated 30/Oct/2026 (ref. no."

Company snapshot

SUDARSHAN is a listed company.

The stock last traded at ₹36.42, against a 52-week range of ₹34.7–₹39.3 (7.3% below the high).

What history shows

BCEIE's records show 3 previous fund raising filings from the company since May 2026.

Market-wide, 1,685 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 47% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • How the money raised is used and, for equity instruments, the dilution for existing shareholders.

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on SUDARSHAN